Red blood cells are responsible for transporting oxygen throughout the body. In dogs with DAMS, the bone marrow produces red blood cells that develop abnormally and may not function efficiently. This can lead to anemia, a condition in which the body lacks sufficient healthy red blood cells to meet its oxygen demands. At the same time, the disorder affects muscle tissue, causing progressive muscle weakness and impaired physical performance.
Clinical signs of DAMS often begin during puppyhood or early adulthood, although the severity and age of onset may vary among affected dogs. Common symptoms include lethargy, weakness, pale gums, reduced stamina, exercise intolerance, muscle wasting, difficulty walking, and delayed recovery after physical activity. Some dogs may exhibit poor growth, weight loss, or generalized fatigue due to decreased oxygen delivery to tissues. As the disease progresses, muscle-related symptoms can become more pronounced, affecting mobility and overall well-being.
The DAMS DNA Health Test is designed to detect the specific genetic mutation associated with Dyserythropoietic Anemia and Myopathy Syndrome. Testing is simple and non-invasive, typically requiring either a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog's genetic status. Since DNA remains unchanged throughout life, testing can be performed at any age, including in puppies before clinical signs appear.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the DAMS mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically unaffected by the disorder. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Dyserythropoietic Anemia and Myopathy Syndrome.
Genetic testing for DAMS provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disorder while maintaining genetic diversity within the breed population. Avoiding the breeding of two carrier dogs significantly decreases the likelihood of producing affected puppies.
For dog owners, knowledge of a dog's genetic status allows for proactive healthcare management and early veterinary monitoring. Dogs identified as affected or at risk may benefit from regular blood testing, physical examinations, and supportive care aimed at managing anemia and preserving muscle function. While there is currently no cure for the underlying genetic condition, early diagnosis can help optimize treatment strategies and improve quality of life.
The Dyserythropoietic Anemia and Myopathy Syndrome (DAMS) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine hematologic and muscular health, and helps reduce the impact of this inherited disorder in future generations. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
